10:34 AM EST - Emerald Health Therapeutics, Inc. : Has filed its financial statements and management discussion and analysis for the fiscal quarter ended March 31, 2018. Revenue proved $373,218, compared to $ 245,708. Net loss was $5 million, compared to a loss of $1.6 million in the prior-year quarter. Emerald Health Therapeutics, Inc.
shares T.EMH are trading down $0.15 at $4.05.
